This adaptive plasticity could explain the limited efficacy of exogenous orexin-A in directly modulating wakefulness in conditions like narcolepsy type 1, where a significant loss of orexin neurons disrupts the network's ability to coordinate wake-promoting circuits effectively [38]. Here, HCRT is linked to narcolepsy-cataplexy syndrome.